144 related articles for article (PubMed ID: 11371370)
21. The molecular pathogenesis of cholangiocarcinoma.
Berthiaume EP; Wands J
Semin Liver Dis; 2004 May; 24(2):127-37. PubMed ID: 15192786
[TBL] [Abstract][Full Text] [Related]
22. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
23. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
Newton HB
Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449
[TBL] [Abstract][Full Text] [Related]
24. Molecularly targeted agents: their promise as cancer chemopreventive interventions.
Thiery-Vuillemin A; Nguyen T; Pivot X; Spano JP; Dufresnne A; Soria JC
Eur J Cancer; 2005 Sep; 41(13):2003-15. PubMed ID: 16098739
[TBL] [Abstract][Full Text] [Related]
25. Molecular aspects of carcinogenesis in pancreatic cancer.
Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
[TBL] [Abstract][Full Text] [Related]
26. [Kinase inhibitors for the therapy of malignant melanoma].
Becker JC; Schrama D; Bröcker EB; Houben R
J Dtsch Dermatol Ges; 2005 Oct; 3(10):762-7. PubMed ID: 16194153
[TBL] [Abstract][Full Text] [Related]
27. [Stem cells and cancer: elucidating the origin of the cancer stem cell].
Bosch Barrera J; López-Picazo González JM; García-Foncillas López J; Prósper Cardoso F
Rev Med Univ Navarra; 2007; 51(2):14-7. PubMed ID: 17886709
[TBL] [Abstract][Full Text] [Related]
28. Centrosomes and cancer: how cancer cells divide with too many centrosomes.
Godinho SA; Kwon M; Pellman D
Cancer Metastasis Rev; 2009 Jun; 28(1-2):85-98. PubMed ID: 19156503
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
Chun KS; Surh YJ
Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
[TBL] [Abstract][Full Text] [Related]
30. ETS transcription factors and their emerging roles in human cancer.
Seth A; Watson DK
Eur J Cancer; 2005 Nov; 41(16):2462-78. PubMed ID: 16213704
[TBL] [Abstract][Full Text] [Related]
31. A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis.
Degenhardt K; White E
Clin Cancer Res; 2006 Sep; 12(18):5298-304. PubMed ID: 17000662
[TBL] [Abstract][Full Text] [Related]
32. Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription.
Spiegelberg BD; Hamm HE
Curr Opin Genet Dev; 2007 Feb; 17(1):40-4. PubMed ID: 17188489
[TBL] [Abstract][Full Text] [Related]
33. A global perspective of radiation-induced signal transduction pathways in cancer therapeutics.
Gupta S; Ahmed MM
Indian J Exp Biol; 2004 Dec; 42(12):1153-76. PubMed ID: 15623227
[TBL] [Abstract][Full Text] [Related]
34. An ordinary differential equation model for the multistep transformation to cancer.
Spencer SL; Berryman MJ; García JA; Abbott D
J Theor Biol; 2004 Dec; 231(4):515-24. PubMed ID: 15488528
[TBL] [Abstract][Full Text] [Related]
35. Relationships between cancer and aging: a multilevel approach.
Anisimov VN; Sikora E; Pawelec G
Biogerontology; 2009 Aug; 10(4):323-38. PubMed ID: 19156531
[TBL] [Abstract][Full Text] [Related]
36. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin.
Raju J; Mehta R
Nutr Cancer; 2009; 61(1):27-35. PubMed ID: 19116873
[TBL] [Abstract][Full Text] [Related]
37. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
38. [Oncogene and tumor suppressor gene].
Watanabe N
Rinsho Byori; 2002 Nov; Suppl 123():131-6. PubMed ID: 12652800
[TBL] [Abstract][Full Text] [Related]
39. Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options.
Ocaña A; Pandiella A
Clin Cancer Res; 2008 Feb; 14(4):961-70. PubMed ID: 18281527
[TBL] [Abstract][Full Text] [Related]
40. New insights on oxidative stress in cancer.
Visconti R; Grieco D
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
